Weijuan Yao Selected Research

melarsonic acid (melarsonyl potassium)

2/2007	Exogenous wild-type p53 gene improved survival of nude mice injected with murine erythroleukemia cell line through amelioration of hemorheological changes.
9/2003	Wild type p53 gene causes reorganization of cytoskeleton and, therefore, the impaired deformability and difficult migration of murine erythroleukemia cells.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Weijuan Yao Research Topics

Disease

8	Neoplasms (Cancer) 01/2017 - 08/2006
4	Acute Erythroblastic Leukemia (Erythroleukemia) 12/2011 - 06/2003
4	Pulmonary Hypertension 07/2011 - 10/2008
2	Chronic Kidney Failure (Chronic Renal Failure) 01/2015 - 01/2011
2	Anemia 11/2012 - 02/2002
2	Pulmonary Arterial Hypertension 07/2011 - 04/2010
1	Vascular Diseases (Vascular Disease) 11/2022
1	Arteriosclerosis 11/2022
1	Inflammation (Inflammations) 11/2022
1	Thrombosis (Thrombus) 01/2022
1	Pathologic Constriction (Stenosis) 01/2022
1	Atherosclerosis 01/2022
1	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2020
1	Hypercholesterolemia 01/2016
1	Hyperuricemia 04/2015
1	Hepatocellular Carcinoma (Hepatoma) 01/2012
1	Leukemia 12/2011
1	Obesity 07/2011
1	Heart Valve Diseases (Valvular Heart Disease) 07/2011
1	Fibrosis (Cirrhosis) 07/2011
1	Familial Primary Pulmonary Hypertension 07/2011
1	Hypoxia (Hypoxemia) 04/2010
1	Poisoning 01/2010
1	Vascular Remodeling 10/2009
1	Neoplasm Metastasis (Metastasis) 08/2006
1	Decompression Sickness (Bends) 09/2003

Drug/Important Bio-Agent (IBA)

3	Proteins (Proteins, Gene)FDA Link 01/2022 - 09/2003
2	Interleukin-10 (Interleukin 10)IBA 01/2020 - 01/2017
2	Biological ProductsIBA 01/2014 - 12/2011
2	CytokinesIBA 01/2014 - 03/2007
2	melarsonic acid (melarsonyl potassium)IBA 02/2007 - 09/2003
1	Adenine FDA LinkGeneric 11/2022
1	Interleukin-6 (Interleukin 6)IBA 11/2022
1	von Willebrand FactorIBA 01/2022
1	VimentinIBA 01/2022
1	dragon's bloodIBA 01/2016
1	Apolipoproteins E (ApoE)IBA 01/2016
1	HypoxanthineIBA 04/2015
1	NF-kappa B (NF-kB)IBA 01/2014
1	Profilins (Profilin)IBA 01/2014
1	Polystyrenes (Polystyrene)IBA 11/2012
1	Polysaccharides (Glycans)IBA 01/2012
1	Telomerase (Telomerase Reverse Transcriptase)IBA 12/2011
1	Complementary DNA (cDNA)IBA 12/2011
1	Phentermine (Adipex-P)FDA LinkGeneric 07/2011
1	FenfluramineIBA 07/2011
1	Protein Isoforms (Isoforms)IBA 04/2010
1	Transcription Factors (Transcription Factor)IBA 04/2010
1	DichlorvosIBA 01/2010
1	Sirolimus (Rapamycin)FDA Link 10/2009
1	Platelet-Derived Growth Factor Receptors (Platelet-Derived Growth Factor Receptor)IBA 10/2008
1	AntigensIBA 03/2007
1	Saline SolutionIBA 01/2005
1	Etoposide (VP 16)FDA LinkGeneric 01/2005
1	Membrane LipidsIBA 09/2003
1	Liposomes (Liposome)IBA 06/2003
1	phenylhydrazine (phenylhydrazine hydrochloride)IBA 02/2002

Therapy/Procedure

3	Immunotherapy 01/2017 - 03/2007
3	Therapeutics 01/2014 - 08/2006
2	Transplantation 01/2015 - 01/2011
2	Kidney Transplantation 01/2015 - 01/2011
1	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2012
1	Intraperitoneal Injections 01/2005